Adtalem Global Education (ATGE) has been on a downward spiral lately with significant selling pressure. After declining 21.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting ...

Core Viewpoint - Adtalem Global Education, Inc. strongly refutes claims made by Safkhet Capital, asserting that the report contains numerous factual errors and misrepresentations regarding the company's performance and operations [1][2][3]. Group 1: Company Performance and Claims - Adtalem is the largest healthcare educator in the U.S., producing more nursing and Doctor of Veterinary Medicine graduates than any other institution [2]. - The company achieved a 98% first-time residency attainment for its medical school graduates last year [2]. - Adtalem's total enrollment increased by 6% as of December 31, 2023, marking the largest increase since acquiring Walden in August 2021 [4]. - Chamberlain University, the nation's largest nursing school, has seen total enrollment growth for four consecutive quarters, including a 7% increase as of December 31, 2023 [4]. - Walden's total enrollment grew by 8% as of December 31, 2023, with strong persistence rates [4]. Group 2: Financial Assertions and Clarifications - The assertion that Adtalem should impair its $1.48 billion acquisition of Walden is incorrect; the most recent impairment test in May 2023 did not identify any impairment [4]. - Adtalem's graduation rates are competitive, with Chamberlain's four-year graduation rate at 71%, significantly higher than the national average of 49% [7]. - The company fully complies with the 90/10 rule, and recent changes in the calculation have had a negligible effect on RUSM's 90/10 rate [10]. - Adtalem's institutions are fully accredited and eligible for Title IV funding, despite claims regarding expired Program Participation Agreements [13]. Group 3: Response to Safkhet Capital's Assertions - Safkhet Capital's claims regarding the borrower defense program and its potential impact on Adtalem are unfounded, as there is no evidence of material risk [12]. - The comparison between Adtalem and Corinthian Colleges is baseless, as the circumstances surrounding their operations and challenges are fundamentally different [14]. - Adtalem's share repurchase claims are misleading; the company maintains a balanced approach to capital allocation, including investments in technology and student support [15]. - The updated executive compensation policy aligns management incentives with long-term shareholder value, contrary to claims made by Safkhet Capital [16].

Second Quarter 2024 Earnings January 30, 2024 ©2024 Adtalem Global Education Inc. All rights reserved Safe FORWARD-LOOKING STATEMENTS ...

To be blunt, buying a Wall Street recommended stock can be a mixed bag. While we trust experts in say the legal and medical fields, it’s a different proposition in the equities space. No matter how smart you are, how many certifications you may have received, or how much time you spent pouring over charts and financials, the harsh reality is this: no one knows what will happen next.So, should you disregard a Wall Street recommended stock? Not necessarily – otherwise, there’d be no point in reading ahead, no ...

Core Insights - Adtalem Global Education Inc. (ATGE) reported strong second-quarter fiscal 2024 results, with earnings and revenues exceeding expectations and showing year-over-year growth [1][2] - The company has raised its fiscal 2024 guidance due to solid enrollment growth and effective execution of its Growth with Purpose strategy [1][8] Earnings & Revenue Discussion - Adjusted earnings per share (EPS) reached $1.23, surpassing the Zacks Consensus Estimate of $1.01 by 21.8% and increasing 51.4% from $1.17 in the same quarter last year [2] - Revenues totaled $393.2 million, exceeding the consensus mark of $374.1 million by 5.1% and reflecting an 8.4% year-over-year increase [2] - Total student enrollment rose 6.2% year over year to 81,772 students, surpassing the predicted enrollment of 77,607 [2] Segment Details - **Chamberlain Segment**: Revenues increased 8.6% to $153.6 million, with total student enrollment up 6.6% to 35,592 students. Adjusted operating income declined 10.8% to $29.6 million [4] - **Walden Segment**: Revenues grew 11.3% to $146.8 million, with total student enrollment rising 7.9% to 40,971 students. Adjusted operating income increased 3.9% to $30.2 million [5] - **Medical and Veterinary Segment**: Revenues grew 3.8% to $92.9 million, but total student enrollment declined 7.5% to 5,209 students [6] Liquidity & Cash Flow - As of December 31, 2023, cash and cash equivalents were $182.9 million, down from $273.7 million at the end of fiscal 2023. Long-term debt increased to $696.4 million [7] - Net cash provided by operating activities for the first six months of fiscal 2024 was $83.1 million, compared to $42.3 million in the prior year [7] Raised Fiscal 2024 Guidance - The company now expects revenues between $1,520 million and $1,560 million, an increase from the previous range of $1,470 million to $1,530 million. Adjusted EPS is projected to be between $4.55 and $4.75, up from $4.25 to $4.45 [8]

Adtalem Global Education (ATGE) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.78%. A quarter ago, it was expected that this for-profit education company would post earnings of $0.82 per share when it actually produced earnings of $0.93, delivering a surprise of 13.41%.Over the la ...

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Adtalem Global Education, Inc. dropped over 23% on January 30, 2024, after Safkhet Capital published a report alleging that the company’s business model uses deceptive tactics and pushes students into debt. Gibbs Law Group is investigating a potential Adtalem Securities Class Action Lawsuit on behalf of shareholders who lost money in Adtalem (NYSE: ATGE). What Should ATGE Investors Do? If you invested in Adtalem Global Education, visit our website by clicking ...

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE) today reported second quarter fiscal 2024 results (ended Dec. 31, 2023) reflecting accelerated total enrollment and revenue growth, underpinned by strong profitability and high-quality academic outcomes through executing Growth with Purpose strategy. “Adtalem once again performed ahead of expectations this quarter, solidifying our position as a leading healthcare educator,” said Steve Beard, president, and chief executive officer, Adtal ...

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), a national leader in post-secondary education and a leading provider of professional talent to the healthcare industry, announced today it will release its fiscal 2024 second quarter results, ahead of schedule, on Tuesday, January 30, 2024, after financial markets close. The company’s earnings announcement was originally scheduled for Thursday, February 1, 2024. In light of market news today, Adtalem has rescheduled its earnings announce ...

BOSTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Adtalem Global Education, Inc. (NYSE:ATGE) for potential securities law violations. Investors who have lost money in their Adtalem Global Education, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/atge. What is this all about? Before the market opened on January 30, 2024, CNBC reported that short seller Fahmi Quadir of Safkhet ...